Literature DB >> 1331537

A mouse mammary tumor virus mammary gland enhancer confers tissue-specific but not lactation-dependent expression in transgenic mice.

E Mok1, T V Golovkina, S R Ross.   

Abstract

The long terminal repeat (LTR) of mouse mammary tumor virus (MMTV) is known to contain a number of transcriptional regulatory elements, including glucocorticoid response elements. In this study, we showed that a mammary gland/salivary gland enhancer found in the LTR of this virus directs expression of a heterologous promoter to both virgin and lactating mammary glands in transgenic mice. Using transgenic mice containing hybrid gene constructs with various deletions of the LTR sequences linked to marker genes, we also showed that the dramatic increase in MMTV expression that occurs during lactation is due to the glucocorticoid response elements. Thus, the MMTV LTR encodes two distinct elements, both of which are required for a high level of expression in lactating mammary glands.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1331537      PMCID: PMC240463     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  19 in total

1.  The Wnt-1 (int-1) oncogene promoter and its mechanism of activation by insertion of proviral DNA of the mouse mammary tumor virus.

Authors:  R Nusse; H Theunissen; E Wagenaar; F Rijsewijk; A Gennissen; A Otte; E Schuuring; A van Ooyen
Journal:  Mol Cell Biol       Date:  1990-08       Impact factor: 4.272

2.  Transcriptional repression of a hormone-responsive promoter.

Authors:  K L Morley; M G Toohey; D O Peterson
Journal:  Nucleic Acids Res       Date:  1987-09-11       Impact factor: 16.971

Review 3.  Steroid receptor regulated transcription of specific genes and gene networks.

Authors:  K R Yamamoto
Journal:  Annu Rev Genet       Date:  1985       Impact factor: 16.830

4.  Negative regulation of transcription in vitro by a glucocorticoid response element is mediated by a trans-acting factor.

Authors:  S J Langer; M C Ostrowski
Journal:  Mol Cell Biol       Date:  1988-09       Impact factor: 4.272

5.  The mouse mammary tumor virus long terminal repeat directs expression in epithelial and lymphoid cells of different tissues in transgenic mice.

Authors:  Y W Choi; D Henrard; I Lee; S R Ross
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

6.  Mouse mammary tumor virus proviruses in T-cell lymphomas lack a negative regulatory element in the long terminal repeat.

Authors:  C L Hsu; C Fabritius; J Dudley
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

7.  Negative regulation in correct tissue-specific expression of mouse mammary tumor virus in transgenic mice.

Authors:  S R Ross; C L Hsu; Y Choi; E Mok; J P Dudley
Journal:  Mol Cell Biol       Date:  1990-11       Impact factor: 4.272

8.  Two regions of the mouse mammary tumor virus long terminal repeat regulate the activity of its promoter in mammary cell lines.

Authors:  P Lefebvre; D S Berard; M G Cordingley; G L Hager
Journal:  Mol Cell Biol       Date:  1991-05       Impact factor: 4.272

9.  Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes.

Authors:  T A Stewart; P K Pattengale; P Leder
Journal:  Cell       Date:  1984-10       Impact factor: 41.582

10.  Structure and nucleotide sequence of the putative mammary oncogene int-1; proviral insertions leave the protein-encoding domain intact.

Authors:  A van Ooyen; R Nusse
Journal:  Cell       Date:  1984-11       Impact factor: 41.582

View more
  19 in total

1.  Overexpression of human Cripto-1 in transgenic mice delays mammary gland development and differentiation and induces mammary tumorigenesis.

Authors:  Youping Sun; Luigi Strizzi; Ahmed Raafat; Morihisa Hirota; Caterina Bianco; Lionel Feigenbaum; Nicholas Kenney; Christian Wechselberger; Robert Callahan; David S Salomon
Journal:  Am J Pathol       Date:  2005-08       Impact factor: 4.307

2.  Stably integrated mouse mammary tumor virus long terminal repeat DNA requires the octamer motifs for basal promoter activity.

Authors:  E Buetti
Journal:  Mol Cell Biol       Date:  1994-02       Impact factor: 4.272

3.  Functional redundancy of octamer elements in the mouse mammary tumor virus promoter.

Authors:  M Huang; J W Lee; D O Peterson
Journal:  Nucleic Acids Res       Date:  1993-11-11       Impact factor: 16.971

4.  MMTV does not encode viral microRNAs but alters the levels of cancer-associated host microRNAs.

Authors:  Rodney P Kincaid; Neena G Panicker; Mary M Lozano; Christopher S Sullivan; Jaquelin P Dudley; Farah Mustafa
Journal:  Virology       Date:  2017-11-05       Impact factor: 3.616

5.  Construction and characterization of a hybrid mouse mammary tumor virus/murine leukemia virus-based retroviral vector.

Authors:  R M Saller; F Oztürk; B Salmons; W H Günzburg
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

6.  Coexpression of exogenous and endogenous mouse mammary tumor virus RNA in vivo results in viral recombination and broadens the virus host range.

Authors:  T V Golovkina; A B Jaffe; S R Ross
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

Review 7.  MMTV infectious cycle and the contribution of virus-encoded proteins to transformation of mammary tissue.

Authors:  Susan R Ross
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-07-26       Impact factor: 2.673

8.  Mammary gland expression of mouse mammary tumor virus is regulated by a novel element in the long terminal repeat.

Authors:  W Qin; T V Golovkina; T Peng; I Nepomnaschy; V Buggiano; I Piazzon; S R Ross
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

9.  Nucleoprotein structure influences the response of the mouse mammary tumor virus promoter to activation of the cyclic AMP signalling pathway.

Authors:  W D Pennie; G L Hager; C L Smith
Journal:  Mol Cell Biol       Date:  1995-04       Impact factor: 4.272

10.  Vascular endothelial growth factor restores delayed tumor progression in tumors depleted of macrophages.

Authors:  Elaine Y Lin; Jiu-feng Li; Gabriel Bricard; Weigang Wang; Yan Deng; Rani Sellers; Steven A Porcelli; Jeffrey W Pollard
Journal:  Mol Oncol       Date:  2007-12       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.